Home UK data presented at EURETINA 2014 showcase efficacy of EYLEA in...
 

Keywords :   


UK data presented at EURETINA 2014 showcase efficacy of EYLEA in...

2014-10-05 15:23:30| Chemicals - Topix.net

Bayer HealthCare reports that data have been presented at the 14th EURETINA congress in London, showcasing the efficacy of EYLEA for the treatment of wet age-related macular degeneration in the real-life setting. Numerous posters presented at the congress, from centres across the UK, highlight that treatment with EYLEA has resulted in improved visual and / or anatomical outcomes in treatment-naive and pre-treated patients.1-4 Commenting on the data, Luis-Felipe Graterol, Medical Director, Bayer HealthCare said, 'It is encouraging to see that the efficacy seen in the clinical trials for Eylea is being reflected in clinical practice and that patients are benefitting from this treatment across the country.

Tags: in data presented showcase

Category:Chemicals

Latest from this category

All news

13.06PCI Announces 2024 Scholarship Recipients
13.06Evonik Develops TEGO Therm Fire-Resistant Coatings for EVs
12.06ACA\'s Andy Doyle Awarded Silver Medal for Outstanding Service by the BCF
12.06MNYCA Hosts Afternoon of Baseball
12.06U.S. Green Building Council Announces Chief Growth Officer and Key Technical Appointments
12.06Michael Maginnis Named Regional Sales Manager at JNS-SmithChem
12.06AkzoNobel Opens World-first Testing Facility for Wind Turbine Blades
11.06Siemens and BASF Collaborate on Driving Circular Economy
Chemicals »
13.06Bank fires employees over fake keyboard activity
13.06Eastern North Pacific Tropical Weather Outlook
13.06Atlantic Tropical Weather Outlook
13.06PCI Announces 2024 Scholarship Recipients
13.06Evonik Develops TEGO Therm Fire-Resistant Coatings for EVs
13.06Suzano Acquires 15% Stake in Lenzing
13.06Ontex Plans Restructuring in Belgium
13.06Printing United Alliance and Stahls partner for education
More »